Capital International Sarl Has $6.43 Million Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Capital International Sarl boosted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 11.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 102,674 shares of the company’s stock after acquiring an additional 10,531 shares during the period. Capital International […]
More Stories
Kaiser Aluminum (NASDAQ:KALU) Announces Earnings Results
Kaiser Aluminum (NASDAQ:KALU – Get Free Report) issued its earnings results on Wednesday. The industrial products company reported $0.51 EPS...
Ausbil Investment Management Ltd Purchases 1,721 Shares of Atmos Energy Co. (NYSE:ATO)
Ausbil Investment Management Ltd raised its stake in shares of Atmos Energy Co. (NYSE:ATO – Free Report) by 2.4% during...
Argent Capital Management LLC Buys 282 Shares of LCI Industries (NYSE:LCII)
Argent Capital Management LLC raised its stake in LCI Industries (NYSE:LCII – Free Report) by 14.5% during the third quarter,...
Ausbil Investment Management Ltd Buys 8,031 Shares of Modine Manufacturing (NYSE:MOD)
Ausbil Investment Management Ltd grew its position in shares of Modine Manufacturing (NYSE:MOD – Free Report) by 42.8% in the...
PG&E Co. (NYSE:PCG) Shares Acquired by Ausbil Investment Management Ltd
Ausbil Investment Management Ltd increased its position in shares of PG&E Co. (NYSE:PCG – Free Report) by 6.0% during the...
ESSA Bancorp Reports Financial Results for September 30, 2024
ESSA Bancorp, Inc., a Pennsylvania-based company, disclosed its financial outcomes for the period ending September 30, 2024. The announcement was...